ProShare Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$443K Sell
17,213
-888
-5% -$20.6K ﹤0.01% 1168
2026
Q1
$372K Sell
18,101
-4,475
-20% -$101K ﹤0.01% 1219
2025
Q4
$535K Buy
22,576
+898
+4% +$21.9K ﹤0.01% 1101
2025
Q3
$540K Sell
21,678
-3,815
-15% -$82.1K ﹤0.01% 1068
2025
Q2
$586K Buy
25,493
+1,198
+5% +$27.7K ﹤0.01% 1041
2025
Q1
$545K Sell
24,295
-6,475
-21% -$150K ﹤0.01% 1044
2024
Q4
$602K Buy
30,770
+9,475
+44% +$188K ﹤0.01% 1170
2024
Q3
$388K Buy
21,295
+4,136
+24% +$78.9K ﹤0.01% 1296
2024
Q2
$298K Sell
17,159
-5,324
-24% -$94.3K ﹤0.01% 1295
2024
Q1
$440K Buy
22,483
+1,562
+7% +$33K ﹤0.01% 1166
2023
Q4
$482K Buy
20,921
+4,262
+26% +$95.4K ﹤0.01% 1057
2023
Q3
$383K Buy
16,659
+5,412
+48% +$138K ﹤0.01% 1062
2023
Q2
$294K Buy
+11,247
New +$297K ﹤0.01% 1284
2022
Q2
Sell
-7,860
Closed -$210K 2049
2022
Q1
$210K Buy
+7,860
New +$186K ﹤0.01% 1860
2021
Q3
Sell
-5,087
Closed -$226K 2204
2021
Q2
$226K Buy
+5,087
New +$188K ﹤0.01% 2078

Other funds holding PRVA

ProShare Advisors's PRVA Position: Q2 2026 in Review

ProShare Advisors reduced its Privia Health (PRVA) stake by 4.9% in Q2 2026, selling an estimated $20.6K and leaving 17,213 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

ProShare Advisors first reported a position in PRVA in Q2 2021 and has held it in 15 quarters since. The position peaked at $602K in Q4 2024. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • ProShare Advisors held 17,213 shares of Privia Health worth $443K as of Q2 2026.
  • ProShare Advisors sold 888 Privia Health shares in Q2 2026, an estimated $20.6K.
  • Privia Health made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1168 holding.
  • ProShare Advisors first reported a position in Privia Health in Q2 2021 and has held it in 15 quarters since.
  • ProShare Advisors's Privia Health position peaked at $602K in Q4 2024.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.